ArticleJournal of translational medicine2023

A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma.

Davide Busato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.